Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study
AbstractWe used data from the baseline survey from the Isfahan Healthy Heart Programme to determine the prevalence of hypertension, dyslipidaemia and diabetes among a representative samples of 12 514 adults living in 3 cities in the Islamic Republic of Iran. The prevalence of hypertension, dyslipidaemia and diabetes was 17.3%, 66.3% and 5.6% respectively. Awareness, treatment and control of hypertension were 40.3%, 35.3%, and 9.1% respectively. The rates for dyslipidaemia were 14.4%, 7.1% and 6.5% respectively, and 54.6% of diabetics were aware of their disease and 46.2% were under treatment
Shirani, S., Kelishadi, R., Sarrafzadegan, N., Khosravi, A., Sadri, Gh. et al. (2009). Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study. http://www.who.int/iris/handle/10665/117785
EMHJ - Eastern Mediterranean Health Journal, 15 (6), 1455-1463, 2009
MetadataShow full item record
Showing items related by title and MeSH subject.
Risk of hypertension in Yozgat province, central Anatolia: application of framingham hypertension prediction risk score Kilic, M.; Ede, H.; Kilic, A.I. (2016-04)The aim of this cross-sectional study was to estimate the risk of hypertension in 1106 Caucasian individuals aged 20-69 years in Yozgat Province, using the Framingham Hypertension Risk Prediction Score [FHRPS]. According to FHRPS, average risk of developing hypertension over 4 years was 6.2%. The participants were classified into low- [<5%], moderate- [5% to 10%] and high- [>10%] risk groups. The percentage of participants that fell into these groups was 59.4%, 19.8% and 20.8% respectively. The proportion of participants in the high-risk group ...